Latest Articles and Analysis

Analyzes CMS marketplace rule changes and Medicaid expansion risks as pandemic emergency declarations end.

Analyzes Biden health policy priorities including drug pricing reform and Medicare expansion.

Overview of the 340B Drug Discount Program for patient advocates covering program history and key policy issues.

Calls for restoring Obama-era guidance defining 340B patient protections and enforcement mechanisms.

Examines CMS's rebate rule on copay accumulator programs that block patient assistance from counting toward deductibles.

Reviews Biden's first 100 days on healthcare: infrastructure, subsidies, harm reduction, and health equity.

Analysis of Kanawha County HIV outbreak highlighting substance use, rural healthcare gaps, and pandemic impact.

Multi-state Hepatitis A and B outbreaks linked to homelessness highlight housing as public health priority.

FDA approves Cabenuva, first long-acting injectable HIV regimen offering monthly alternative to daily pills.

Narrowly divided Senate limits Biden's health policy agenda, making regulatory actions the primary reform path.

Final rule allowing drug importation from Canada poses safety risks from counterfeit medications.

CANN outlines advocacy priorities for the Biden era, from 340B reform and drug pricing to HIV criminalization and health equity.